您的当前位置:首页 > 行业数据 > 2018-2023年我国仿制药一致性评价进展
图片属性
图片格式:PNG 图片大小:86KB 图片尺寸:1713*1038
同报告图片
 / 4
2018-2023年我国仿制药一致性评价进展_第1页
fCDlubTku70gfCDov4for4Tlj5fnkIblj7fmgLvmlbDvvIjku7bvvIkgfCDop4blkIzpgJrov4fmlbDvvIjku7bvvIkgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgMjAxOOW5tCB8IDEyOCB8IDg1IHwKfCAyMDE55bm0IHwgNDI3IHwgMzA2IHwKfCAyMDIw5bm0IHwgMTA5OSB8IDYxMiB8CnwgMjAyMeW5tCB8IDE4ODQgfCAxMDM0IHwKfCAyMDIy5bm0IHwgMTcwNCB8IDg2MyB8CnwgMjAyM+W5tCB8IDIxMDQgfCA4MjkgfAoK6LWE5paZ5p2l5rqQ77ya5Lit5Zu95Yy76I2v5Yib5paw5L+D6L+b5Lya77yMQ0RF77yM6K+a6YCa6K+B5Yi456CU56m25omA
2018-2023年我国仿制药一致性评价进展_第2页
2018-2023年我国仿制药一致性评价进展_第3页
2018-2023年我国仿制药一致性评价进展_第4页
2018-2023年我国仿制药一致性评价进展_第5页
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
所属报告: 山东药玻-公司首次覆盖报告:药玻行业龙头政策红利成本下降双受益-241202(27页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠